How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion

导出原文传递

翻译打印收藏纠错

作者： Sarzi-Puttini, Piercarlo ^[1] ; Marotto, Daniela ^[2] ; Antivalle, Marco ^[3] ; Salaffi, Fausto ^[4] ; Atzeni, Fabiola ^[5] ; Maconi, Giovanni ^[6] ; Monteleone, Giovanni ^[7] ; Rizzardini, Giuliano ; Antinori, Spinello ; Galli, Massimo ; Ardizzone, Sandro

作者单位： Univ Milan, L Sacco Dept Biochem & Clin Sci, Rheumatol Unit, ASST Fatebenefratelli Sacco, Milan ^[1] Univ Milan, L Sacco Hosp, Luigi Sacco Dept Biomed & Clin Sci, Div Infect Dis 3, Milan, Italy ^[2] ASST Fatebenefratelli Sacco, Div Infect Dis 1, Dept Infect Dis, Milan, Italy ^[3] Univ Milan, Milan L Sacco Dept Biochem & Clin Sci, Gastroenterol Unit, ASST Fatebenefratelli Sacco ^[4] Univ Politecn Marche, Osped Carlo Urbani, Rheumatol Clin, Ancona, Italy ^[5] Univ Messina, Rheumatol Unit, Messina, Italy ^[6] Tor Vergata Univ Rome, Dept Syst Med, Rome, Italy ^[7]

关键词 COVID-19 Inflammatory bowel disease Rheumatic disease Infection Treatment DMARDs Small molecules bDMARDs Prevention Flow-chart

发布时间 2020-12-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交